The potential of proton beam radiation therapy in breast cancer

References

• Cancer Incidence in Sweden. Epidemiologiskt Centrum. 2003; www.sos.se.
   Google Scholar
• Rutqvist LE, Rose C, Cavallin-Ståhl E. A systematic overview of radiation therapy effects in breast cancer. Acta Oncol 2003; 42: 532–45
   PubMed Web of Science ®Google Scholar
• Ragaz J, Jackson SM, Le N, Plenderleith IH, Spinelli JJ, Basco VE, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997; 337: 956–62
   PubMed Web of Science ®Google Scholar
• Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 1997; 337: 949–55
   PubMed Web of Science ®Google Scholar
• Overgaard M, Jensen MB, Overgaard J, Hansen PS, Rose C, Andersson M, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet 1999; 353: 1641–8
   PubMed Web of Science ®Google Scholar
• Early Breast Cancer Trialists' Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 2000; 355: 1757–70
   PubMed Web of Science ®Google Scholar
• Whelan TJ, Julian J, Wright J, Jadad AR, Levine ML. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 2000; 18: 1220–9
   PubMed Web of Science ®Google Scholar
• Huang EH, Tucker SL, Strom EA, McNeese MD, Kuerer HM, Buzdar AU, et al. Postmastectomy radiation improves local-regional control and survival for selected patients with locally advanced breast cancer treated with neoadjuvant chemotherapy and mastectomy. J Clin Oncol 2004; 22: 4691–9
   PubMed Web of Science ®Google Scholar
• Foroudi F, Tyldesley S, Walker H, Mackillop WJ. An evidence-based estimate of appropriate radiotherapy utilization rate for breast cancer. Int J Radiat Oncol Biol Phys 2002; 53: 1240–53
   PubMed Web of Science ®Google Scholar
• Recht A, Edge SB, Solin LJ, Robinson DS, Estabrook A, Fine RE, et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001; 19: 1539–69
   PubMed Web of Science ®Google Scholar
• Truong PT, Olivotto IA, Whelan TJ, Levine M. Clinical practice guidelines for the care and treatment of breast cancer: 16. Locoregional post-mastectomy radiotherapy. CMAJ 2004; 170: 1263–73
   PubMed Web of Science ®Google Scholar
• Möller TR, Brorsson B, Ceberg J, Frodin JE, Lindholm C, Nylen U, et al. A prospective survey of radiotherapy practice 2001 in Sweden. Acta Oncol 2003; 42: 387–410
   PubMed Web of Science ®Google Scholar
• American Society of Breast Surgeons. Consensus statement for accelerated partial breast irradiation. Bethesda, MD: American Society of Breast Surgeons; 2003 April 30.
   Google Scholar
• Meric F, Buchholz TA, Mirza NQ, Vlastos G, Ames FC, Ross MI, et al. Long-term complications associated with breast-conservation surgery and radiotherapy. Ann Surg Oncol 2002; 9: 543–9
   PubMed Web of Science ®Google Scholar
• Host H, Brennhovd IO, Loeb M. Postoperative radiotherapy in breast cancer–long-term results from the Oslo study. Int J Radiat Oncol Biol Phys 1986; 12: 727–32
   PubMed Web of Science ®Google Scholar
• Rutqvist LE, Lax I, Fornander T, Johansson H. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys 1992; 22: 887–96
   PubMed Web of Science ®Google Scholar
• Gyenes G, Rutqvist LE, Liedberg A, Fornander T. Long-term cardiac morbidity and mortality in a randomized trial of pre- and postoperative radiation therapy versus surgery alone in primary breast cancer. Radiother Oncol 1998; 48: 185–90
   PubMed Web of Science ®Google Scholar
• Darby S, McGale P, Peto R, Granath F, Hall P, Ekbom A. Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women. BMJ 2003; 326: 256–7
   PubMed Web of Science ®Google Scholar
• Hojris I, Overgaard M, Christensen JJ, Overgaard J. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: analysis of DBCG 82b and 82c randomised trials. Radiotherapy Committee of the Danish Breast Cancer Cooperative Group. Lancet 1999; 354: 1425–30
   PubMed Web of Science ®Google Scholar
• Giordano SH, Kuo YF, Freeman JL, Buchholz TA, Hortobagyi GN. Goodwin JS. Risk of cardiac death after adjuvant radiotherapy for breast cancer. J Natl Cancer Inst 2005; 97: 419–24
   PubMedGoogle Scholar
• Pedersen AN, Korreman S, Nystrom H, Specht L. Breathing adapted radiotherapy of breast cancer: reduction of cardiac and pulmonary doses using voluntary inspiration breath-hold. Radiother Oncol 2004; 72: 53–60
   PubMed Web of Science ®Google Scholar
• Gagliardi G, Bjohle J, Lax I, Ottolenghi A, Eriksson F, Liedberg A, et al. Radiation pneumonitis after breast cancer irradiation: analysis of the complication probability using the relative seriality model. Int J Radiat Oncol Biol Phys 2000; 46: 373–81
   PubMed Web of Science ®Google Scholar
• Hardman PD, Tweeddale PM, Kerr GR, Anderson ED, Rodger A. The effect of pulmonary function of local and loco-regional irradiation for breast cancer. Radiother Oncol 1994; 30: 33–42
   PubMed Web of Science ®Google Scholar
• Lind PA, Gagliardi G, Wennberg B, Fornander T. A descriptive study of pulmonary complications after postoperative radiation therapy in node-positive stage II breast cancer. Acta Oncol 1997; 36: 509–15
   PubMed Web of Science ®Google Scholar
• Lind PA, Wennberg B, Gagliardi G, Fornander T. Pulmonary complications following different radiotherapy techniques for breast cancer, and the association to irradiated lung volume and dose. Breast Cancer Res Treat 2001; 68: 199–210
   PubMed Web of Science ®Google Scholar
• Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 1991; 21: 123–35
   PubMed Web of Science ®Google Scholar
• Gray JR, McCormick B, Cox L, Yahalom J. Primary breast irradiation in large-breasted or heavy women: analysis of cosmetic outcome. Int J Radiat Oncol Biol Phys 1991; 21: 347–54
   PubMed Web of Science ®Google Scholar
• Johansson S, Svensson H, Larsson LG, Denekamp J. Brachial plexopathy after postoperative radiotherapy of breast cancer patients–a long-term follow-up. Acta Oncol 2000; 39: 373–82
   PubMed Web of Science ®Google Scholar
• Johansson S. Late side-effects following radiotherapy after mastectomy in breast cancer patients. A long-term follow-up: Thesis, Umeå University; 2000.
   Google Scholar
• Travis L. Therapy-associated secondary solid cancer. Acta Oncol 2002; 41: 323–33
   PubMed Web of Science ®Google Scholar
• Boice JD, Jr, Harvey EB, Blettner M, Stovall M, Flannery JT. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 1992; 326: 781–5
   PubMed Web of Science ®Google Scholar
• Turesson I, Carlsson J, Brahme A, Glimelius B, Zackrisson B, Stenerlow B. and the Swedish Cancer Society Investigation Group Biological response to radiation therapy. Acta Oncol 2003;42:92–106.
   PubMed Web of Science ®Google Scholar
• Intensity Modulated Radiation Therapy Collaborative Working Group. Intensity-modulated radiotherapy: Current status and issues of interest. Int J Radiat Oncol Biol Phys 2001; 51: 880–914
   PubMedGoogle Scholar
• Glimelius B, Isacsson U, Blomquist E, Grusell E, Jung B, Montelius A. Potential gains using high-energy protons for therapy of malignant tumours. Acta Oncol 1999; 38: 137–45
   PubMed Web of Science ®Google Scholar
• Lomax A. Intensity modulation methods for proton radiotherapy. Phys Med Biol 1999; 44: 185–205
   PubMed Web of Science ®Google Scholar
• Muren LP, Maurstad G, Hafslund R, Anker G, Dahl O. Cardiac and pulmonary doses and complication probabilities in standard and conformal tangential irradiation in conservative management of breast cancer. Radiother Oncol 2002; 62: 173–83
   PubMed Web of Science ®Google Scholar
• Reed DR, Lindsley SK, Mann GN, Austin-Seymour M, Korssjoen T, Anderson BO, et al. Axillary lymph node dose with tangential breast irradiation. Int J Radiat Oncol Biol Phys 2005; 61: 358–64
   PubMed Web of Science ®Google Scholar
• Hurkmans CW, Borger JH, Bos LJ, van der Horst A, Pieters BR, Lebesque JV, et al. Cardiac and lung complication probabilities after breast cancer irradiation. Radiother Oncol 2000; 55: 145–51
   PubMed Web of Science ®Google Scholar
• Hurkmans CW, Cho BC, Damen E, Zijp L, Mijnheer BJ. Reduction of cardiac and lung complication probabilities after breast irradiation using conformal radiotherapy with or without intensity modulation. Radiother Oncol 2002; 62: 163–71
   PubMed Web of Science ®Google Scholar
• Cho BC, Hurkmans CW, Damen EM, Zijp LJ, Mijnheer BJ. Intensity modulated versus non-intensity modulated radiotherapy in the treatment of the left breast and upper internal mammary lymph node chain: a comparative planning study. Radiother Oncol 2002; 62: 127–36
   PubMedGoogle Scholar
• Hurkmans CW, Saarnak AE, Pieters BR, Borger JH, Bruinvis IA. An improved technique for breast cancer irradiation including the locoregional lymph nodes. Int J Radiat Oncol Biol Phys 2000; 47: 1421–9
   PubMed Web of Science ®Google Scholar
• Johansson J, Isacsson U, Lindman H, Montelius A, Glimelius B. Node-positive left-sided breast cancer patients after breast-conserving surgery: potential outcomes of radiotherapy modalities and techniques. Radiother Oncol 2002; 65: 89–98
   PubMed Web of Science ®Google Scholar
• Lomax AJ, Cella L, Weber D, Kurtz JM, Miralbell R. Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes. Int J Radiat Oncol Biol Phys 2003; 55: 785–92
   PubMed Web of Science ®Google Scholar
• Lomax A, Boehringer T, Coray A, et al. Intensity modulated proton therapy: a clinical example. Med Phys 2001; 28: 317–24
   PubMed Web of Science ®Google Scholar
• Severin D, Connors S, Thompson H, Rathee S, Stavrev P, Hanson J. Breast radiotherapy with inclusion of internal mammary nodes: a comparison of techniques with three-dimensional planning. Int J Radiat Oncol Biol Phys 2003; 55: 633–44
   PubMedGoogle Scholar
• Lundkvist J, Ekman M, Rehn Ericsson S, Isacsson U, Jönsson B, Glimelius B. Economic evaluation of proton radiation therapy in the treatment of breast cancer. Radiother Oncol 2005; 75: 179–85
   PubMed Web of Science ®Google Scholar
• Veronesi U, Marubini E, Mariani L, Valagussa P, Zucali R. The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomised trial. Eur J Cancer 1999; 35: 1320–5
   PubMed Web of Science ®Google Scholar
• Lievens Y, Poortmans P, Van den Bogaert W. A glance on quality assurance in EORTC study 22922 evaluating techniques for internal mammary and medial supraclavicular lymph node chain irradiation in breast cancer. Radiother Oncol 2001; 60: 257–65
   PubMedGoogle Scholar
• Mansur DB, El Naqa I, Kong F, Klein EE, Taylor ME, Zoberi I, et al. Localization of internal mammary lymph nodes by CT simulation: implications for breast radiation therapy planning. Radiother Oncol 2004; 73: 355–7
   PubMedGoogle Scholar
• Seidman A, Hudis C, Pierri MK, Shak S, Paton V, Ashby M, et al. Cardiac dysfunction in the trastuzumab clinical trials experience. J Clin Oncol 2002; 20: 1215–21
   PubMed Web of Science ®Google Scholar
• Taghian AG, Assaad SI, Niemierko A, Floyd SR, Powell SN. Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer?. Int J Radiat Oncol Biol Phys 2005; 62: 386–91
   PubMed Web of Science ®Google Scholar
• Gyenes G, Fornander T, Carlens P, Glas U, Rutqvist LE. Detection of radiation-induced myocardial damage by technetium-99m sestamibi scintigraphy. Eur J Nucl Med 1997; 24: 286–92
   PubMedGoogle Scholar
• Hardenbergh PH, Munley MT, Bentel GC, Kedem R, Borges-Neto S, Hollis D, et al. Cardiac perfusion changes in patients treated for breast cancer with radiation therapy and doxorubicin: preliminary results. Int J Radiat Oncol Biol Phys 2001; 49: 1023–8
   PubMed Web of Science ®Google Scholar